ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

GEN Gen Digital Inc

25,40
0,58 (2,34%)
Dernière mise à jour : 20:10:25
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Gen Digital Inc GEN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,58 2,34% 25,40 20:10:25
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
24,88 24,88 25,405 24,82
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
28/5/202417:00PRNUSGen Releases its Fiscal 2024 Social Impact Report
21/5/202417:06GLOBEGenmab Completes Acquisition of ProfoundBio
17/5/202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202403:51EDGAR2Form 144 - Report of proposed sale of securities
15/5/202403:55EDGAR2Form 144 - Report of proposed sale of securities
15/5/202402:01EDGAR2Form 144 - Report of proposed sale of securities
14/5/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202409:00PRNUSDeepfakes, AI-Manipulated Audio, and Hijacked Social Media..
10/5/202422:15EDGAR2Form 8-K - Current report
10/5/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202413:58IHMARKETNEWSJFrog and Akamai Drop Over 10% Despite Strong Profits;..
09/5/202422:06EDGAR2Form 8-K - Current report
09/5/202422:05PRNUSGen Delivers Fifth Consecutive Year of Organic Growth and..
02/5/202417:01GLOBEGenmab Announces Financial Results for the First Quarter of..
30/4/202400:40GLOBETIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval..
23/4/202409:01PRNUSSwipe Right on Safety: New Study from Norton Finds 64% of..
16/4/202422:02PRNUSGen to Announce Fiscal 2024 Fourth Quarter and Full-Year..
10/4/202415:00PRNUSGen Brands Norton, Avast, AVG and Avira Earn 16 Award..
03/4/202417:00PRNUSAvast Continues Expansion of its Avast One Family of..
03/4/202407:34GLOBEGenmab to Broaden and Strengthen Oncology Portfolio with..
14/3/202414:00PRNUSTax Prep Service Scams Rank High on Taxpayers' List of..
21/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202417:41GLOBEGenmab Announces Initiation of Share Buy-Back Program
14/2/202417:02GLOBEGenmab Publishes 2023 Annual Report
07/2/202415:00PRNUSAvast Blocks Record Breaking 10 Billion Attacks in 2023,..
05/2/202423:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202422:09EDGAR2Form 8-K - Current report
01/2/202422:05PRNUSGen Reports 18th Consecutive Quarter of Growth in Q3 FY24
31/1/202415:00PRNUSReputationDefender Releases Total Radius to Help Protect..
24/1/202423:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17/1/202415:00PRNUSNorton Partners with Award-Winning Creator Dan Levy to Bring..
11/1/202422:02PRNUSGen to Announce Fiscal 2024 Third Quarter Results on..
07/12/202315:00PRNUSGen Reveals Cybersecurity Predictions for 2024
05/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202315:10IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
16/11/202315:00PRNUSAvast Blocks All-Time High of 1 Billion Unique Cyber Attacks..
15/11/202314:30PRNUSSeekr Announces Secure Browser
14/11/202315:00PRNUSNorton Declares November 26 "Cyber Safety Sunday,"..
09/11/202315:14GLOBEMajor Shareholder Announcement
08/11/202317:09GLOBEMajor Shareholder Announcement
07/11/202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202317:01GLOBEGenmab Announces Financial Results for the First Nine Months..